Rani Therapeutics Holdings Management
Management criteria checks 2/4
Rani Therapeutics Holdings' CEO is Talat Imran, appointed in Jun 2021, has a tenure of 2.83 years. total yearly compensation is $5.27M, comprised of 8.5% salary and 91.5% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth $1.29M. The average tenure of the management team and the board of directors is 2.8 years and 3 years respectively.
Key information
Talat Imran
Chief executive officer
US$5.3m
Total compensation
| CEO salary percentage | 8.5% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$5m | US$450k | -US$34m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$34m |
| Mar 31 2023 | n/a | n/a | -US$33m |
| Dec 31 2022 | US$4m | US$515k | -US$31m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$22m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | US$12m | US$408k | -US$8m |
Compensation vs Market: Talat's total compensation ($USD5.27M) is above average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Talat's compensation has increased whilst the company is unprofitable.
CEO
Talat Imran (41 yo)
2.8yrs
Tenure
US$5,266,893
Compensation
Mr. Talat Imran serves as an Investment Professional at VHM Ventures. He has served as Chief Executive Officer and Director of Rani Therapeutics Holdings, Inc. since June 2021 and served as its Vice Presid...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | no data | US$398.55k | 0.029% $ 102.0k | |
| CEO & Director | 2.8yrs | US$5.27m | 0.37% $ 1.3m | |
| Chief Financial Officer | 5.4yrs | US$2.16m | 0.16% $ 550.1k | |
| Chief Scientific Officer | 10.8yrs | US$2.17m | 0.17% $ 586.2k | |
| General Counsel | 2.8yrs | no data | 0.022% $ 76.8k | |
| Vice President of Human Resources | 3.3yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data | |
| Vice President of Clinical Development | no data | no data | no data |
2.8yrs
Average Tenure
52.5yo
Average Age
Experienced Management: RANI's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | no data | US$398.55k | 0.029% $ 102.0k | |
| CEO & Director | 2.8yrs | US$5.27m | 0.37% $ 1.3m | |
| Lead Independent Director | 3yrs | US$436.47k | 0.52% $ 1.8m | |
| Independent Director | 3yrs | US$393.97k | 0.19% $ 664.3k | |
| Independent Director | 5.6yrs | US$378.10k | 0.000060% $ 207.5 | |
| Director | 11.8yrs | US$363.55k | 0.00024% $ 830.2 | |
| Independent Director | 7.8yrs | US$396.60k | 0.044% $ 151.5k | |
| Independent Director | 2.3yrs | US$388.62k | 0.14% $ 498.6k |
3.0yrs
Average Tenure
63yo
Average Age
Experienced Board: RANI's board of directors are considered experienced (3 years average tenure).